Antiphospholipid syndrome and homozygous factor V Leiden mutation in a young patient with Libman-Sacks endocarditis and stroke
Morissette, N.; Gorman, T.
American Journal of Medicine 123(9): E3-E4
2010
ISSN/ISBN: 1555-7162 PMID: 20800139 DOI: 10.1016/j.amjmed.2010.01.033Document Number: 213142
Document emailed within 0-6 h
Related Documents
Plotnicki, T.; Plotnicki, B. 1972: Non-bacterial verrucous endocarditis and the Libman-Sacks syndrome Wiadomosci Lekarskie 25(16): 1455-1457Ansari, A.U.; Bates, H.; Larson, P.H. 1984: Is Libman-Sacks endocarditis an immune complex disease? Minnesota Medicine 67(12): 681-682
Sasahashi, N.; Aono, N.; Kuji, T.; Shinoka, T.; Sueshiro, M.; Tomino, T. 1992: A case of mitral valve replacement for Libman-Sacks endocarditis Nihon Kyobu Geka Gakkai 40(1): 155-160
Ginanjar, E.; Yulianto, Y. 2017: Autoimmune Disease with Cardiac Valves Involvement: Libman-Sacks Endocarditis Acta Medica Indonesiana 49(2): 148-150
Kotaka, M.; Kohchi, A. 2003: Perioperative management of a patient with factor V Leiden mutation Masui. Japanese Journal of Anesthesiology 52(4): 409-411
Takatsu, T.; Kubo, S.; Nishioka, A.; Morita, H.; Sonotani, N. 1977: Hypertension and endocarditis in systemic lupus erythematosus--relationship between lupus nephritis and hypertension, Libman-Sacks disease Nihon Rinsho. Japanese Journal of Clinical Medicine 35(6): 2202-2214
Kolbach, D.N.; Boer, J. 1998: A young patient with chronic recurrent leg ulcers; hyperhomocysteinemia and heterozygote for factor V Leiden Nederlands Tijdschrift Voor Geneeskunde 142(49): 2706-2707
Castoldi, E.; Kalafatis, M.; Lunghi, B.; Simioni, P.; Ioannou, P.A.; Petio, M.; Girolami, A.; Mann, K.G.; Bernardi, F. 1998: Molecular bases of pseudo-homozygous APC resistance: the compound heterozygosity for FV R506Q and a FV null mutation results in the exclusive presence of FV Leiden molecules in plasma Thrombosis and Haemostasis 80(3): 403-406
Cadroy, Y.; Sié, P.; Alhenc-Gelas, M.; Aiach, M. 1995: Evaluation of APC resistance in the plasma of patients with Q506 mutation of factor V (factor V Leiden) and treated by oral anticoagulants Thrombosis and Haemostasis 73(4): 734-735
Fijnheer, R.; Horbach, D.A.; Donders, R.C.; Vilé, H.; von Oort, E.; Nieuwenhuis, H.K.; Gmelig-Meijling, F.H.; de Groot, P.G.; Derksen, R.H. 1996: Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus Thrombosis and Haemostasis 76(4): 514-517
Schröder, W.; Koessling, M.; Wulff, K.; Wehnert, M.; Herrmann, F.H. 1996: World distribution of factor V Leiden mutation Lancet 347(8993): 58-59
Fouéré, S.; Guibal, F.; Morel, P. 1996: World distribution of factor V Leiden mutation Lancet 347(8993): 59
Paseka, J.; Unzeitig, V.; Cibula, D.; Buliková, A.; Matýsková, M.; Chroust, K. 2000: The factor V Leiden mutation in users of hormonal contraceptives Ceska Gynekologie 65(3): 156-159
Yong, A.Anning.; Tan, A.Wei.Hsia.; Giam, Y.Chin.; Tang, M.Boon.Yang. 2012: Livedoid vasculopathy and its association with factor V Leiden mutation Singapore medical journal 53(12): e258-e260
2001: Summaries for patients. Blood clots in people with the factor V Leiden mutation Annals of Internal Medicine 135(5): S-34
Melegh, B.; Stankovics, J.; Kis, A.; Nagy, A.; Storcz, J.; Losonczy, H.; Méhes, K. 1998: Increased prevalence of factor V Leiden mutation in neonatal intracranial haemorrhage European Journal of Pediatrics 157(3): 261
Verheggen, P.W.; Heymans, B.T.; Slagboom, P.E.; Haverkate, F.; Cats, V.M. 1997: Normal prevalence of factor V Leiden gene mutation in patients with severe unstable angina Thrombosis and Haemostasis 77(6): 1218
Narawane, N.M.; Phadke, A.Y.; Shah, S.K.; Bhandarkar, P.V.; Abraham, P. 2000: Jejunal stricture complicating acute mesenteric venous thrombosis secondary to protein C deficiency and factor V Leiden gene mutation Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 19(2): 79-80
Beris, P.H.; Darbellay, R.; Beck, D.; Oner, R. 1991: Concomitant inheritance of homozygous alpha-thalassemia-2 with homozygous IVS-I-5 G-C beta gene mutation does not influence the severity of the thalassemic phenotype Nouvelle Revue Francaise d'Hematologie 33(3): 227-230
Howard, T.E.; Marusa, M.; Channell, C.; Duncan, A. 1997: A patient homozygous for a mutation in the prothrombin gene 3'-untranslated region associated with massive thrombosis Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 8(5): 316-319